NDC 0338-6010
Milrinone Lactate in Dextrose 0.2 mg per 1 mL injection, solution
On the label: Baxter Healthcare Corporation.
Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Baxter Healthcare Corporation | Jayuya, PR, United States | Makes it, tests it, packages it, labels it and sterilizes it | Problems found, fixed voluntarilyJul 19, 2024 · 15 inspections, 5 with FDA action |
| Baxter Healthcare Corporation | Round Lake, IL, United States | Tests it | Serious problems, FDA actionApr 2, 2026 · 15 inspections, 2 with FDA action |
Recalls
- May 15, 2017 · Class II · Baxter Healthcare Corporation
Lack of assurance of sterility: customer complaints received for the presence of leaks.
Lots: Lot #: P342485, Exp 11/30/17; P344408, Exp 12/31/17
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Milrinone: every company that makes it
- Form
- injection, solution, intravenous
- Strength
- 0.2 mg per 1 mL
- Approval
- ANDA ANDA075834
- On the market since
- May 28, 2002
- Package NDCs
0338-6010-48- Official label
- DailyMed (National Library of Medicine), updated May 30, 2018
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?